General Information
Revision date
2024-04-03
Product name
KAPA NGS Extraction Buffer (10X) Kapa : KK7351
1.2.1 Relevant identified uses
Laboratory chemicals, Refer to product literature for further details
Emergency telephone
+49(0)621-759-2203, +49(0)6131-19240
Icons in SDS
Company Information
company name
Roche Diagnostics Deutschland GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info.dia-sds@roche.com
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. KAPA NGS Extraction Buffer (10X) 2
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Not a hazardous substance or mixture. 2.2 Label elements Labelling (REGULATION (EC) No 1272/2008) No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) required 2.3 Other hazards This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Ecological information: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Toxicological information: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. KAPA NGS Extraction Buffer (10X) 2 SECTION 3: Composition/information on ingredients 3.2 Mixtures Components For explanation of abbreviations see section 16. Remarks : No hazardous ingredients SECTION 4: First aid measures 4.1 Description of first aid measures General advice : Do not leave the victim unattended. If inhaled : Move to fresh air. If unconscious, place in recovery position and seek medical advice. If symptoms persist, call a physician. In case of skin contact : If on skin, rinse well with water. In case of eye contact : Immediately flush eye(s) with plenty of water. Remove contact lenses. Protect unharmed eye.